Skip to Content

Elite Pharmaceuticals Inc ELTP Stock Quote

| Rating as of


Last close prices updated as of Feb 03, 2023, 3:15 PM EST | USD
  • Last Close 0.03705
  • Sector Healthcare
  • Industry Drug Manufacturers - Specialty & Generic
  • Investment Style
  • Day Range 0.04  –  0.04
  • Year Range 0.03  –  0.05
  • Market Cap 37.5656 Mil
  • Volume / Avg 16,356.0 /  366,003.9
  • Price / Sales 1.14
  • Price / Book 1.38
  • Forward Div Yield 1.33%
  • Trailing Div Yield

Morningstar‘s Stock Analysis ELTP

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics ELTP

Company Profile ELTP

Business Description

Elite Pharmaceuticals Inc is a pharmaceutical company. It is principally engaged in the development and manufacture of oral, controlled-release products, using proprietary know-how and technology. The company's operating segment includes Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). It generates maximum revenue from the ANDA segment. The company focuses on developing pain management products; manufacturing of a line of generic pharmaceutical products with approved Abbreviated New Drug Applications; development of additional generic pharmaceutical products; development of the other products in its pipeline including the products with its partners; and commercialization of new products.

165 Ludlow Avenue
Northvale, NJ, 07647
Industry Drug Manufacturers - Specialty & Generic
Employees 43

FAQs for Elite Pharmaceuticals Inc Stock

Yes. ELTP has a forward dividend yield of 1.33%. See ELTP’s full dividends and stock split history on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

ELTP’s market cap is 37.57 Mil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

ELTP’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare ELTP’s historical performance against its industry peers and the overall market.